Table 2

Frontline therapy in breast cancer before and during lockdown

Front-line therapy in breast cancer (n=552)
ParameterBefore lockdown
(March 16, 2019 to
May 31, 2019)
During lockdown
(March 16, 2020 to
May 31, 2020)
Difference (%)P value
Primary surgery238 (68%)102 (51%)−17%<0.001*
Neoadjuvant chemotherapy77 (22%)81 (40%)+18%
Neoadjuvant endocrine therapy27 (8%)16 (8%)0%
No therapy9 (2%)2 (1%)−1%
Total351201
  • 2 test.